UK cost body finally approves limited use of GSK's lupus drug

LONDON (Reuters) - Britain's healthcare cost watchdog has finally approved GlaxoSmithKline's lupus drug Benlysta for limited use, after rejecting it since 2011 on the grounds that it failed to offer good value for money.

Source: Reuters: Health - May 10, 2016 Category: Consumer Health News Tags: healthNews Source Type: news